Gilead Sciences
GILD
#141
Rank
$153.65 B
Marketcap
$123.76
Share price
-1.35%
Change (1 day)
16.55%
Change (1 year)

Gilead Sciences (GILD) - Net assets

Net assets on the balance sheet as of March 2026 : $23.43 Billion USD

According to Gilead Sciences's latest financial reports the company has $23.43 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Gilead Sciences - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$$22.61 B17.52%
2024-12-31$$19.24 B-15.4%
2023-12-31$$22.74 B7.26%
2022-12-31$$21.20 B0.69%
2021-12-31$$21.06 B15.6%
2020-12-31$$18.22 B-19.55%
2019-12-31$$22.65 B5.18%
2018-12-31$$21.53 B5.04%
2017-12-31$$20.50 B5.88%
2016-12-31$$19.36 B1.31%
2015-12-31$$19.11 B20.82%
2014-12-31$$15.81 B34.69%
2013-12-31$$11.74 B23.07%
2012-12-31$$9.54 B38.97%
2011-12-31$$6.86 B12.18%
2010-12-31$$6.12 B-5.89%
2009-12-31$$6.50 B45.67%
2008-12-31$$4.46 B24.03%
2007-12-31$$3.60 B92.65%
2006-12-31$$1.86 B-38.28%
2005-12-31$$3.02 B61.84%
2004-12-31$$1.87 B86.53%
2003-12-31$$1.00 B75.55%
2002-12-31$$0.57 B26.28%
2001-12-31$$0.45 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
$81.18 B 246.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$90.40 B 285.83%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
-$6.62 Billion-128.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$31.19 B 33.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$9.19 B-60.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$18.65 B-20.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
$2.67 B-88.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
$19.36 B-17.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$45.93 B 96.03%๐Ÿ‡บ๐Ÿ‡ธ USA